SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (304)11/8/1999 2:03:00 AM
From: Dan Gibbs  Read Replies (1) of 372
 
It's great to get some input from a chemist. Frankly, I would be tickled if 10% of new drugs each year used peptide building blocks. NZYM has positioned itself as a preferred provider for several pharmaceutical companies and while there is competition, I think the company will get a large share of the business for new drugs using amino acids, especially the highly modified synthetic amino acids. As you say, it won't take many of these to create some significant "base hits" if not home runs for NZYM.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News